08045800513
Send Inquiry
Send InquiryMetformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg
Metformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg Specification
- Drug Type
- Specific Drug
- Ingredients
- Metformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg
- Physical Form
- Tablets
- Function
- Other
- Recommended For
- 3rd line treatment for Type 2 Diabetes Mellitus, when all other treatment fails
- Suitable For
- Adults, Aged Person
Metformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg Trade Information
- Payment Terms
- Western Union, Paypal, Cash Advance (CA), Cash in Advance (CID), Cheque
- Sample Policy
- Sample costs shipping and taxes has to be paid by the buyer
- Packaging Details
- Blister Pack, 2*5*10
- Main Export Market(s)
- Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Central America, Asia
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Metformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg
Metformin-500 mg, Glibenclamide 5 mg, and Pioglitazone 15 mg tablets are designed for the targeted management of Type 2 Diabetes Mellitus, particularly as a third-line treatment option when standard therapeutic approaches fail. Formulated with a precise combination of active ingredients, these tablets ensure effective glycemic control by addressing multiple mechanisms of action. Metformin reduces glucose production in the liver, Glibenclamide stimulates pancreatic insulin secretion, and Pioglitazone enhances insulin sensitivity in peripheral tissues. Suitable for adults and aged individuals, this specific drug is an optimal solution for healthcare providers handling challenging diabetic cases. Manufactured in tablet form, they offer convenience and reliability for patients requiring advanced diabetes management strategies.
FAQs of Metformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg:
Q: What is the recommended use for this product?
A: This tablet is recommended as a third-line treatment for Type 2 Diabetes Mellitus when all other treatment options fail.Q: Who is this product suitable for?
A: It is suitable for adults and aged individuals requiring advanced diabetes management.Q: How does this product work?
A: Metformin reduces liver glucose production, Glibenclamide stimulates insulin secretion, and Pioglitazone enhances insulin sensitivity.Q: What is the physical form of this product?
A: This product is available in tablet form for convenience and efficacy.Q: What type of drug is this?
A: This is a specific drug formulated for targeted treatment of Type 2 Diabetes Mellitus.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Diabetic Tablets Category
Metformin 500 mg & 1000 mg (Sustained Release)
Drug Type : Specific Drug
Ingredients : Metformin 500 mg & 1000 mg
Function : Other
Physical Form : Tablets
Recommended For : Type 2 Diabetes Mellitus
Suitable For : Adults, Aged Person
Metformin-500 mg & Glibenclamide 5 mg
Drug Type : Specific Drug
Ingredients : Metformin500 mg & Glibenclamide 5 mg
Function : Other
Physical Form : Tablets
Recommended For : Type 2 Diabetes Mellitus, NIDDM with vascular complication
Suitable For : Adults, Aged Person
Glimperide, Metformin & Pioglitazone Combination (Extended Release)
Drug Type : Specific Drug
Ingredients : Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg (ER) Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg (ER)
Function : Other
Physical Form : Tablets
Recommended For : Management of Type 2 diabetes (NIDDM)
Suitable For : Adults, Aged Person
Metformin,Glimperide & Atorvastatin Combination
Drug Type : Specific Drug
Ingredients : ExeedAG1: (Metformin 500 mg + Glimpride 1 mg + Atorvastatin 10 mg), ExeedAG2: (Metformin 500 mg + Glimpride 2 mg + Atorvastatin 10 mg)
Function : Other
Physical Form : Tablets
Recommended For : Treatment of Type 2 Diabetes Mellitus associated with dyslipidemia
Suitable For : Adults, Aged Person
Contact Details
- Plot No. 73, Industrial Area, Phase-2,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
